Johnson & Johnson (NYSE:JNJ) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Application (sBLA) for subcutaneous ...

Currently, the Department of Education prohibits the use of phones and other electronic gadgets during class time, except for ...

Summit Therapeutics Inc. today reported its financial results for the second quarter and six months ended June 30, 2026 and provided an update on clinical and operational progress. "The clinical ...

Priority Review reinforces the significant potential of subcutaneous amivantamab in recurrent or metastatic head and neck cancer, where the current five-year survival rate is only 15 percent Patients ...

Second quarter revenue of $1,105 million decreased 4% sequentially Second quarter operating income of $107 million decreased 13% ...

The Companion Pass is still an extremely valuable benefit.

Non-GAAP - refer to the section titled Non-GAAP Financial Measures Defined and GAAP to Non-GAAP Financial Measures Reconciled HOUSTON, July 21, 2026 (GLOBE NEWSWIRE) -- Weatherford International plc ...

You don't want your kids to think you're a dinosaur—bring your knowledge up to date with these new facts.

Spread the love“`html The conversation around Artificial Intelligence in our K-12 classrooms has been building for a while ...

Spread the love“`html Alright, let’s talk about something that’s quietly, or maybe not so quietly, transforming the very ...